All news

(Image: Getty/Martin Barraud)

July roundup: Regulators experience a busy month

By Ben Hargreaves

July has seen a number of actions taken by regulators to manage the supply of medicine, including a crackdown on CBD manufacturers and repackers of opioid medication.

(Image: Getty/greenleaf123)

FDA greenlights nine Lyrica generics

By Vassia Barba

Nine companies, including Teva, Alembic and Amneal receive US FDA approval for generic versions of Pfizer’s blockbuster Lyrica.